Precigen Announces Up to $125 Million Non-Dilutive Financing
Provided By PR Newswire
Last update: Sep 3, 2025
$100 million funded at close fortifies balance sheet and supports robust US commercialization of PAPZIMEOS, as well as potential expansion into international markets and the pursuit of pediatric and other HPV-related indications
Read more at prnewswire.com
